Gene Therapy of Endothelial Nitric Oxide Synthase and Manganese Superoxide Dismutase Restores Delayed Wound Healing in Type 1 Diabetic Mice
- 19 October 2004
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 110 (16) , 2484-2493
- https://doi.org/10.1161/01.cir.0000137969.87365.05
Abstract
Background— Nitric oxide (NO) deficiency contributes to diabetic wound healing impairment. The present study tested the hypothesis that increased cutaneous superoxide (O2−) levels in type 1 diabetic mice cause NO deficiency and delayed wound healing. Methods and Results— Wound healing was markedly delayed in streptozotocin-induced type 1 diabetic mice compared with the normal controls. There were significantly reduced levels of endothelial NO synthase (eNOS) protein and constitutive NOS activity in diabetic wounds, whereas O2− levels were markedly increased. A single regimen of cutaneous gene therapy of eNOS or manganese superoxide dismutase (MnSOD) restored such healing delay, with a concomitant suppression of wound O2− levels and augmentation of both eNOS protein and constitutive NOS activity. Gene therapy of MnSOD also increased cutaneous MnSOD activity. Cutaneous O2− levels were also increased in Ins2Akita diabetic mice. In vitro glucose treatment of cutaneous tissues from normal mice for 24 hours increased O2− levels in a concentration-dependent manner. The enhanced cutaneous O2− levels induced by high glucose in both normal and diabetic mice were abolished by the NADPH oxidase inhibitor apocynin and the protein kinase C inhibitor chelerythrine. Furthermore, ex vivo gene transfer of dominant-negative HA-tagged N17Rac1, which inhibits NADPH oxidase subunit Rac1, significantly inhibited cutaneous O2− formation induced by high glucose in both normal and Ins2Akita diabetic mice. Conclusions— These results indicate that hyperglycemia augments cutaneous O2− levels, at least in part, via NADPH oxidase and protein kinase C pathways, resulting in impaired wound healing in type 1 diabetic mice. Gene therapy strategies aimed at restoring cutaneous NO bioavailability may provide an effective means to ameliorate delayed diabetic wound healing.Keywords
This publication has 42 references indexed in Scilit:
- Increased Superoxide Production in Coronary Arteries in HyperhomocysteinemiaArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- High Glucose Causes Upregulation of Cyclooxygenase-2 and Alters Prostanoid Profile in Human Endothelial CellsCirculation, 2003
- Endothelin-1 Increases Vascular Superoxide via Endothelin A –NADPH Oxidase Pathway in Low-Renin HypertensionCirculation, 2003
- Analysis of the Cytosolic Proteome in a Cell Culture Model of Familial Amyotrophic Lateral Sclerosis Reveals Alterations to the Proteasome, Antioxidant Defenses, and Nitric Oxide Synthetic PathwaysJournal of Biological Chemistry, 2003
- Oxidant-induced Vascular Endothelial Growth Factor Expression in Human Keratinocytes and Cutaneous Wound HealingJournal of Biological Chemistry, 2002
- Nitric oxide drives skin repair: Novel functions of an established mediatorKidney International, 2002
- Biochemistry and molecular cell biology of diabetic complicationsNature, 2001
- Reversal of impaired wound repair in iNOS-deficient mice by topical adenoviral-mediated iNOS gene transfer.Journal of Clinical Investigation, 1998
- Enhancement of wound repair with a topically applied nitric oxide‐releasing polymerWound Repair and Regeneration, 1996
- Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P.Journal of Clinical Investigation, 1994